Articles

Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.

There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s.

The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio

Low-volatility stocks give investors a smoother ride — and they are beating the market on a risk-adjusted basis.

The blowout jobs report is bad news for stocks — but it shouldn’t force the Fed’s hand on interest rates

Rate hikes now will choke off the critical investments needed to lower prices.

Can SpaceX live up to Wall Street’s multitrillion-dollar hype?

As SpaceX prepares for the biggest public debut in history, some analysts warn that the company’s “moonshot” projections could fall short.

America’s crude inventories are getting perilously low. But that’s not the full story.

U.S. commercial oil inventories may be too low for comfort as the war with Iran enters its fourth month far from a clear resolution — and a lot is riding on how much longer the conflict drags on.

Apple’s WWDC will be a make-or-break moment for the company’s fledgling AI strategy

At Monday’s keynote, Apple will get a second chance to show users it can make Siri smarter and more contextually aware.

The key to the upcoming Fed meeting? How Warsh reacts to all the hints of a rate hike.

The new Fed chair might make swift changes to how the central bank communicates.

‘He’s very short-tempered’: My husband won’t sell his home so we can combine our finances and live in comfort. Am I unreasonable?

“Our homes are 20 miles apart, and he still drives back and forth almost daily.”

S&P 500 sees $1.8 trillion wipeout, Nasdaq tallies biggest point drop on record: What investors need to know about Friday’s selloff

A remarkable two-month sprint higher for major stock-market indexes encountered its first major hiccup on Friday as the Nasdaq Composite plummeted more than 1,121 points — the biggest one day point drop on record, according to Dow Jones Market Data.

Bitcoin is suffering from an ‘attention’ deficit, as momentum traders have moved on

“The AI trade is sucking the blood out of crypto,” one analyst notes.

First Google, now Meta? Big Tech may increasingly sell stock to bankroll $820 billion AI boom.

Stock investors may not love it — but bond investors already heavily engaged in funding the AI buildout are pleased.

These stocks fell the most Friday as Big Tech took a dive

Chip makers dominated the list of the day’s biggest losers among the S&P 500.
1 61 62 63 64 65 2,689